488 related articles for article (PubMed ID: 14738657)
21. [Gonorrhea infection as a risk indicator for cervix cancer].
Furgyik S
Geburtshilfe Frauenheilkd; 1987 May; 47(5):320-3. PubMed ID: 3609675
[TBL] [Abstract][Full Text] [Related]
22. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
[TBL] [Abstract][Full Text] [Related]
23. Effect of cervical disease history on outcomes of women who have a pap diagnosis of atypical glandular cells of undetermined significance.
Raab SS; Bishop NS; Zaleski MS
Gynecol Oncol; 1999 Sep; 74(3):460-4. PubMed ID: 10479510
[TBL] [Abstract][Full Text] [Related]
24. Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982.
Lynge E; Poll P
IARC Sci Publ; 1986; (76):69-86. PubMed ID: 3570417
[TBL] [Abstract][Full Text] [Related]
25. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
[TBL] [Abstract][Full Text] [Related]
26. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
27. The 'Pap' or cervical smear and the role of colposcopy in screening for carcinoma of the cervix.
Singh P; Ilancheran A
Singapore Med J; 1989 Jun; 30(3):302-5. PubMed ID: 2686037
[TBL] [Abstract][Full Text] [Related]
28. Optimal frequency of screening for cervical cancer: a Toronto case-control study.
Clarke EA; Hilditch S; Anderson TW
IARC Sci Publ; 1986; (76):125-31. PubMed ID: 3570399
[TBL] [Abstract][Full Text] [Related]
29. Validity of self-reported Pap smear history in Norwegian women.
Klungsøyr O; Nygård M; Skare G; Eriksen T; Nygård JF
J Med Screen; 2009; 16(2):91-7. PubMed ID: 19564522
[TBL] [Abstract][Full Text] [Related]
30. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
31. Cervical changes associated with progestagen-only contraceptives: a team approach.
Darwish A; Labeeb S; Galal M; Rashad H; Hassan S
Contraception; 2004 Feb; 69(2):121-7. PubMed ID: 14759616
[TBL] [Abstract][Full Text] [Related]
32. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
33. Correlates of intent to seek unnecessary pap tests among elderly women.
Zhang Y; Borders TF; Rohrer JE
Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
[TBL] [Abstract][Full Text] [Related]
34. [Results of the study of 96,483 cervical smears of young females up to 30 years of age. A review 5 years following the expansion of a preventive care program].
Bierfreund B
Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):804-7. PubMed ID: 3803874
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer screening. Past success and future challenge.
Dewar MA; Hall K; Perchalski J
Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
[TBL] [Abstract][Full Text] [Related]
36. [Cytologic anamnesis of patients with invasive cervix cancer].
Lasnik E; Breitenecker G
Geburtshilfe Frauenheilkd; 1987 Aug; 47(8):555-7. PubMed ID: 3653669
[TBL] [Abstract][Full Text] [Related]
37. Pap screening and knowledge of risk factors for cervical cancer in Chinese women in British Columbia, Canada.
Hislop TG; Teh C; Lai A; Ralston JD; Shu J; Taylor VM
Ethn Health; 2004 Aug; 9(3):267-81. PubMed ID: 15370000
[TBL] [Abstract][Full Text] [Related]
38. Pap smears with reactive cellular changes: a prospective study.
Ding DC; Hsu S; Chen SS; Hsu YH
J Reprod Med; 2007 Oct; 52(10):938-40. PubMed ID: 17977169
[TBL] [Abstract][Full Text] [Related]
39. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
40. Severe cervical glandular cell lesions and severe cervical combined lesions: predictive value of the papanicolaou smear.
van Aspert-van Erp AJ; Smedts FM; Vooijs GP
Cancer; 2004 Aug; 102(4):210-7. PubMed ID: 15368312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
